Mynvax
PrivateLast Round
Series A
Extension
May 24, 2024
Est. Valuation
$31M
Total Funding Raised
$6.8M
Company Overview
Mynvax is a biotechnology company that develops innovative drugs intended for use in influenza vaccines, focusing on treatments for flu and infectious diseases to support healthcare professionals in enhancing patient recovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mynvax Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Mynvax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 24, 2024 | ||||
| Series A | Jul 19, 2021 | ||||
| Grant | Aug 1, 2020 | ||||
| Angel | Oct 18, 2018 |
Mynvax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inviga Healthcare Fund | Series A Extension |
| Kotak Investment Advisors | Series A |
| 1Crowd | Series A |
| Accel | Series A |
Mynvax Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mynvax's valuation, stock price, and market status.